GetTopicDetailResponse(id=439e11583569, topicName=SHR-1701, introduction=, content=非小細胞肺癌 SHR-1701, image=null, comments=0, allHits=823, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Jun 24 17:04:01 CST 2024, time=2024-06-24, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=492109, tagList=[TagDto(tagId=492109, tagName=SHR-1701)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2244608, encodeId=42f22244608ff, content=<a href='/topic/show?id=0a9e922085f' target=_blank style='color:#2F92EE;'>#貝伐珠單抗#</a> <a href='/topic/show?id=18d293422fd' target=_blank style='color:#2F92EE;'>#轉(zhuǎn)移性結(jié)直腸癌#</a> <a href='/topic/show?id=fe8d18812fb' target=_blank style='color:#2F92EE;'>#XELOX#</a> <a href='/topic/show?id=439e11583569' target=_blank style='color:#2F92EE;'>#SHR-1701#</a>, objectTitle=STTT | SHR-1701聯(lián)合XELOX和貝伐珠單抗一線治療不可切除轉(zhuǎn)移性結(jié)直腸癌的療效和安全性, objectType=article, longId=856087, objectId=24f485608ef5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241219/1734613463104_6145188.png, objectUrl=/article/show_article.do?id=24f485608ef5, replyNumber=0, likeNumber=55, createdTime=2024-12-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=加利福尼亞, moduleDTOList=[ModuleDTO(moduleId=24f485608ef5, moduleTitle=STTT | SHR-1701聯(lián)合XELOX和貝伐珠單抗一線治療不可切除轉(zhuǎn)移性結(jié)直腸癌的療效和安全性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=24f485608ef5)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2243482, encodeId=b2b522434827c, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#結(jié)直腸癌#</a> <a href='/topic/show?id=439e11583569' target=_blank style='color:#2F92EE;'>#SHR-1701#</a>, objectTitle=中山大學(xué)STTT：突破性進展！SHR-1701組合治療顯著提升晚期結(jié)直腸癌患者生存希望, objectType=article, longId=855875, objectId=b4ab8558e5a7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240812/1723427795598_8538692.png, objectUrl=/article/show_article.do?id=b4ab8558e5a7, replyNumber=0, likeNumber=55, createdTime=2024-12-19, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=b4ab8558e5a7, moduleTitle=中山大學(xué)STTT：突破性進展！SHR-1701組合治療顯著提升晚期結(jié)直腸癌患者生存希望, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b4ab8558e5a7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2211456, encodeId=fd96221145631, content=<a href='/topic/show?id=32af9938ec6' target=_blank style='color:#2F92EE;'>#非小細胞肺癌#</a> <a href='/topic/show?id=439e11583569' target=_blank style='color:#2F92EE;'>#SHR-1701#</a>, objectTitle=吳一龍團隊最新Cancer Cell，為不可切除III期非小細胞肺癌的治療提供更多的選擇, objectType=article, longId=830986, objectId=aec38309862a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240622/1719047369091_5579292.png, objectUrl=/article/show_article.do?id=aec38309862a, replyNumber=0, likeNumber=110, createdTime=2024-06-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=aec38309862a, moduleTitle=吳一龍團隊最新Cancer Cell，為不可切除III期非小細胞肺癌的治療提供更多的選擇, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=aec38309862a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-06-24發(fā)表于上海
